NLRP3 and pericarditis: Although all pharmacological agents tested could alleviate inflammation tosome extent, drugs directly or indirectly targeting the NLRP3 inflammasomepathway (i.e., colchicine, 16673-34-0, anakinra, and IL-1 trap) were able toattenuate the pathological changes occurring after acute pericarditis.